{"filing":{"accession_number":"0001193125-26-245186","cik":"0001590750","ticker":"VRDN","company_name":"Viridian Therapeutics, Inc.\\DE","form":"8-K","filing_date":"2026-05-28","report_date":null,"primary_document":"d111506d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1590750/000119312526245186/d111506d8k.htm"},"events":[{"id":10424,"run_id":9140,"accession_number":"0001193125-26-245186","anchor_item_number":"1.02","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.72,"summary":"Viridian completed a voluntary prepayment of approximately $55.1 million to fully satisfy and terminate its Loan and Security Agreement with Hercules Capital. While this is a material debt payoff event, it does not fit cleanly into the standard taxonomy categories. It is not a covenant breach (the company proactively paid), not a going-concern disclosure, and not a typical M\u0026A or financing event. The termination of a material debt facility is material to investors as it affects the company's capital structure and financial obligations, but the absence of a dedicated \"debt payoff\" or \"loan termination\" category makes \"other_material\" the most appropriate classification.","company_name":"Viridian Therapeutics, Inc.\\DE","ticker":"VRDN","filing_date":"2026-05-28","form":"8-K","submitted_at":null,"items":[{"id":6737,"accession_number":"0001193125-26-245186","item_number":"1.02","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.72,"reasoning":"Viridian completed a voluntary prepayment of approximately $55.1 million to fully satisfy and terminate its Loan and Security Agreement with Hercules Capital. While this is a material debt payoff event, it does not fit cleanly into the standard taxonomy categories. It is not a covenant breach (the company proactively paid), not a going-concern disclosure, and not a typical M\u0026A or financing event. The termination of a material debt facility is material to investors as it affects the company's capital structure and financial obligations, but the absence of a dedicated \"debt payoff\" or \"loan termination\" category makes \"other_material\" the most appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:20:34.170546+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":6737,"accession_number":"0001193125-26-245186","item_number":"1.02","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.72,"reasoning":"Viridian completed a voluntary prepayment of approximately $55.1 million to fully satisfy and terminate its Loan and Security Agreement with Hercules Capital. While this is a material debt payoff event, it does not fit cleanly into the standard taxonomy categories. It is not a covenant breach (the company proactively paid), not a going-concern disclosure, and not a typical M\u0026A or financing event. The termination of a material debt facility is material to investors as it affects the company's capital structure and financial obligations, but the absence of a dedicated \"debt payoff\" or \"loan termination\" category makes \"other_material\" the most appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:20:34.170546+00:00","company_name":"Viridian Therapeutics, Inc.\\DE","ticker":"VRDN","filing_date":"2026-05-28"}]}